Cancer Family
Infection-Related Malignant Neoplasm
CI-CAN-00000206Explore in graph →
133 active trials4 approved drugs1 evidence items
- NCIt
- C27223
Loading cancer entity…
Cancer Family
CI-CAN-00000206Explore in graph →
Clinical trials
539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (75)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04474821 | HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults | completed | Phase 4 | 100 | Mayo ClinicOTHER | 1 | Jan 12, 2026 | clinicaltrials |
| NCT03451071 | Postpartum HPV Vaccination | completed | Phase 4 | 195 | University of Alabama at BirminghamOTHER | 1 | Oct 4, 2021 | clinicaltrials |
| NCT02624349 |
| Immunogenicity and Safety of Human Papilloma Virus Vaccine in Solid Organ Transplant Recipients |
| completed |
| Phase 4 |
| 37 |
| The Hospital for Sick ChildrenOTHER |
| 1 |
| Feb 15, 2021 |
| clinicaltrials |
| NCT03105856 | FASTER-Tlalpan Study in Mexico: HPV Vaccination Impact on Cervical Cancer Screening Program(FASTER) | completed | Phase 4 | 3,000 | Instituto Nacional de Salud Publica, MexicoOTHER | 1 | Aug 10, 2020 | clinicaltrials |
| NCT03226119 | MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study | completed | Phase 4 | 150 | MP Biomedicals, LLCINDUSTRY | 1 | Sep 13, 2018 | clinicaltrials |
| NCT00444379 | Anti-Retrovirals for Kaposi's Sarcoma(ARKS) | completed | Phase 4 | 224 | University of California, San FranciscoOTHER | 1 | Aug 20, 2014 | clinicaltrials |
| NCT01418430 | Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) | completed | Phase 4 | — | King's College Hospital NHS TrustOTHER | 1 | Aug 22, 2011 | clinicaltrials |
| NCT00380770 | HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT(KAART) | completed | Phase 4 | 112 | University of KwaZuluOTHER | 1 | Jul 21, 2010 | clinicaltrials |
Data updated 22 days agoSource updated Jan 12, 2026source: clinicaltrials